Site içinde arama yapın | SPORTIVO Network

rishika_2003 bir ses eklendi Health
2026-03-16 11:33:59

Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired Infections
According to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
rishika_2003 bir ses eklendi Health
2026-03-16 11:35:37

Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired Infections
According to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-08 09:15:51

Ceftazidime Avibactam Market Growth & CAGR 9.7% Forecast
According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...

0 Yorumlar 0 hisse senetleri 689 Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-08 09:17:41

Ceftazidime Avibactam Market Growth & CAGR 9.7% Forecast
According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...

0 Yorumlar 0 hisse senetleri 697 Views 0 önizleme

Please log in to like, share and comment!
priyanka bir ses eklendi Health
2025-12-19 06:02:48

Global Ataxia Market Strategic Analysis and Industry Forecast
The Global Ataxia Market Size Was Valued at USD 23.12 Billion in 2023 and is Projected to Reach USD 37.43 Billion by 2032, Growing at a CAGR of 5.50% From 2024-2032. Ataxia is a neurological sign consisting of a lack of voluntary coordination of muscle movements that can include gait abnormality, speech changes, and abnormalities in eye movements. The ataxia market focuses on the development...

0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-09 12:58:09

Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)
According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...

0 Yorumlar 0 hisse senetleri 971 Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-09 12:58:44

Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)
According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...

0 Yorumlar 0 hisse senetleri 988 Views 0 önizleme

Please log in to like, share and comment!
Vanshika bir ses eklendi Health
2026-03-16 12:52:03

Global Multiple Drug Resistance Bacterial Infection Treatment Market Share Analysis by Geography – Industry Forecast to 2031
The global Multiple Drug Resistance Bacterial Infection Treatment Market is becoming increasingly vital as the incidence of antimicrobial resistance (AMR) escalates across the world. Multidrug‑resistant (MDR) bacterial infections represent a critical public health threat, with resistant pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii reducing the...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!
rishika_2003 bir ses eklendi Health
2026-03-18 05:24:18

Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection Burden
According to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...

0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-03-23 10:30:18

Hospital-Acquired Disease Testing Market to Reach USD 724 Million by 2031 | CAGR 5.6%
According to a newly published market research report by 24LifeSciences, global hospital-acquired disease testing market was valued at USD 498 million in 2024 and is projected to reach USD 724 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2026–2034. Hospital-acquired infections (HAIs), clinically significant as nosocomial...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-06 10:26:01

Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%
According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
Kumud bir ses eklendi Health
2026-04-06 10:28:17

Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%
According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!

Arama Sonuçları